Truth vs Test: The Value of Cotinine in Lung Transplant Candidates Assessment
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.02.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Javier Zuazaga-Fuentes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Department, Marqués de Valdecilla University Hospital, Santander, Spain. Hauptthemen laut MEDLINE: Lung Transplantation, Cotinine, Pulmonary Disease, Chronic Obstructive, Lung Diseases, Interstitial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) account for approximately 80% of all lung transplantations. Cotinine, the main nicotine metabolite, can be measured in serum and is a reliable biomarker of tobacco exposure. According to ISHLT consensus, use of any nicotine-containing product is an absolute contraindication for lung transplantation. This study aimed to assess the frequency and characteristics of active smokers among lung transplant candidates. METHODS: We conducted a retrospective study including all patients with COPD or ILD evaluated as lung transplant candidates for the first time at a transplant referral center between November 1, 2020, and December 1, 2023. Serum cotinine was measured using an automated immunoassay (IMMULITE 2000, Siemens HealthCare), with levels >20 ng/mL considered positive. RESULTS: Of 467 total candidates, 356 patients with COPD or ILD underwent cotinine testing at their initial evaluation (median age 61.86 years). Most were former smokers (90.7%) with a median cumulative tobacco exposure of 40 pack-years. Cotinine was elevated in 52 patients (16.1%). Those with positive cotinine levels were more likely to have COPD, be women, be significantly younger, have higher cumulative tobacco exposure, and report a shorter duration of smoking cessation. Candidates with negative cotinine levels had a higher probability of being listed for transplantation. CONCLUSIONS: A substantial proportion of lung transplant candidates show biochemical evidence of active smoking. Younger patients, women, and those with heavier smoking histories and shorter abstinence periods require closer monitoring. Further studies will assess the influence of personality traits on smoking relapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Respiratory Department, Marqués de Valdecilla University Hospital, Santander, Spain.
- Respiratory Department, Lung Transplant Unit, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), Marqués de Valdecilla University Hospital, Frankfurt am Main, Germany; Valdecilla Research Institute (IDI…
- Respiratory Department, Lung Transplant Unit, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), Marqués de Valdecilla University Hospital, Frankfurt am Main, Germany.
- Clinical Analysis and Biochemistry Department, Marqués de Valdecilla University Hospital, Santander, Spain; Valdecilla Research Institute (IDIVAL), Santander, Spain.
- Valdecilla Research Institute (IDIVAL), Santander, Spain.
- Respiratory Department, Lung Transplant Unit, Marqués de Valdecilla University Hospital, Santander, Spain.
Zitieren
APA
Zuazaga-Fuentes, J., Mora-Cuesta, V. M., Iturbe-Fernández, D., Tello-Mena, S., Izquierdo-Cuervo, S., García-Unzueta, M. T., Alonso-Lecue, P., Novoa-Vela, V., & Cifrián-Martínez, J. M. (2026). Truth vs Test: The Value of Cotinine in Lung Transplant Candidates Assessment. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.02.021
Vancouver
Zuazaga-Fuentes J, Mora-Cuesta VM, Iturbe-Fernández D, Tello-Mena S, Izquierdo-Cuervo S, García-Unzueta MT, et al. Truth vs Test: The Value of Cotinine in Lung Transplant Candidates Assessment. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.02.021
BibTeX
@article{ZuazagaFuentes2026,
author = {Zuazaga-Fuentes, Javier and Mora-Cuesta, Víctor M and Iturbe-Fernández, David and Tello-Mena, Sandra and Izquierdo-Cuervo, Sheila and García-Unzueta, María Teresa and Alonso-Lecue, Pilar and Novoa-Vela, Vanesa and Cifrián-Martínez, José M},
title = {Truth vs Test: The Value of Cotinine in Lung Transplant Candidates Assessment},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.02.021}
}
EUVIMED